超选择子宫动脉化疗栓塞术前介入治疗Ⅱ期宫颈癌42例  

Clinical analysis of pre-operation ultraselection uterine arerial chemotherapy and embobization in stage Ⅱ cervical cancer

作　　者：于翠革[1] 黄剑峰[1] 朱克修[2] 孙华[1] 董永安[1] 

机构地区：[1]陕西省人民医院 [2]西安交通大学医学院第一附属医院妇产科,西安710061

出　　处：《陕西医学杂志》2009年第6期698-699,共2页Shaanxi Medical Journal

摘　　要：目的:探讨期宫颈癌术前介入化疗加栓塞的临床价值。方法:对42例期宫颈癌患者术前采用Selinger技术子宫动脉插管化疗加栓塞后行宫颈癌根治术,观察介入治疗的疗效。结果:经介入治疗后所有宫颈癌患者症状均得到缓解,肿块有所缩小,38例患者在介入治疗后14～21d接受了宫颈癌根治术。结论:经子宫动脉介入化疗、栓塞对期巨块型宫颈癌有满意的近期疗效。Objective： To evaluate the clinical efficacy of pre-operation chemotherapy and embobization in stage Ⅱ cervical cancer. Methods： 42 patients in stage Ⅱ cervical cancer were treated with transcatheter uterine arteerial chemotherapy and embolization before surgery. The Selding＇s technique was used in all patients,to evaluate efficacy of interventionat therapy. Results：Clinical symptoms were released in all patients . the size of tumor was decreased in 38 patients surgically treated after 14-21 days interventional chemotherapy and embobization . Conclusion： Preoperation intraarterial chemotherapy and embolization are effective in the short-term treating stage Ⅱ cervical cancer and improve the efficacy of the surgery, it can be used as the routine adjunctive therapy in high-risk early-stage patients （especially locally advanced cervical cancer）.

关 键 词：子宫颈肿瘤/治疗 术前用药法 导管插入术 外周 栓塞 治疗性 

分 类 号：R735.2[医药卫生—肿瘤] R735.7[医药卫生—临床医学]